The Board of Directors of Wardwizard Healthcare Limited (Formerly known as Ayoki Merchantile Limited) at its meeting held today, i.e Monday, 11th August, 2025, has transacted and approved ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wardwizard Healthcare's board approved the unaudited standalone financial results for Q1 FY26 (quarter ended June 30, 2025) on August 11, 2025. Total income stood at ₹63.25 lakhs, mainly driven by ₹43.83 lakhs of other income, while revenue from operations was just ₹19.42 lakhs compared to nil in the same quarter last year. The company reported a net loss of ₹20.81 lakhs, a significant improvement from the ₹110.81 lakhs loss in Q4 FY25. However, the auditor flagged an emphasis of matter noting that the company has temporarily suspended its business operations as it re-strategizes its operations geographically, and management is reviewing the feasibility of future operations.
While the loss has narrowed sharply, the temporary suspension of business and the auditor's emphasis on the company re-evaluating its operations raise serious concerns about the company's near-term prospects. Shareholders should monitor management's next update on the feasibility review, as continued operational suspension could pressure the stock.